Intermittent catheterization in paraplegic patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001205:Ascorbic Acid / Q000627:therapeutic use; D001626:Bethanechol Compounds / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008709:Methenamine / Q000627:therapeutic use; D008875:Middle Aged; D010264:Paraplegia / Q000601:surgery*; D010277:Parasympathomimetics / Q000627:therapeutic use; D013119:Spinal Cord Injuries / Q000601:surgery*; D014546:Urinary Catheterization / Q000009:adverse effects; D014552:Urinary Tract Infections / Q000188:drug therapy; D014556:Urine / Q000382:microbiology
D001626:Bethanechol Compounds; D010277:Parasympathomimetics; D008709:Methenamine; D001205:Ascorbic Acid